CRITICAL APPRAISAL OF EFFECTIVENESS OF ORAL FINGOLIMOD ON RELAPSING MULTIPLE SCLEROSIS
Oral fingolimod has been recently accepted as a treatment for relapsing Multiple Sclerosis (MS) by the Indonesian Food and Drug Administration. The number of MS patients is increasing in Indonesia. There is a critical need of systematically reviewing the new medication for both efficacy and safety....
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universitas Sanata Dharma
2017-11-01
|
| Series: | Jurnal Farmasi Sains dan Komunitas |
| Subjects: | |
| Online Access: | http://e-journal.usd.ac.id/index.php/JFSK/article/view/606 |